Pyrazine

Pyrazine

SCHEMBL2649926

NNC(=O)NN.c1cnccn1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
CYP1A2 P05177 3/20 0.48
CYP3A4 P08684 2/20 0.48
ADORA3 P0DMS8 2/20 0.48
MPO P05164 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2A6 P11509 1/20 0.48
CYP2C19 P33261 1/20 0.48
MDM2 Q00987 1/20 0.40
P2RX7 Q99572 3/20 0.39
TSHR P16473 2/20 0.37
NFKB1 P19838 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
THPO P40225 1/20 0.37
LMNA P02545 1/20 0.35
ALDH1A1 P00352 2/20 0.35
TAAR1 Q96RJ0 2/20 0.34
CYP2C9 P11712 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL4655282 0.86 TDP1 (0.47) KDM4ECYP1A2CYP3A4ADORA3MPO
Pyrazine SCHEMBL27913358 0.81 CYP1A2 (0.62) KDM4ECYP1A2CYP3A4ADORA3MPO
SCHEMBL64716 0.79
SCHEMBL10623380 0.79 NFKB1 (0.54) KDM4ECYP1A2CYP3A4MPOP2RX7
SCHEMBL20178517 0.79 NFKB1 (0.54) KDM4ECYP1A2CYP3A4MPOP2RX7
Benzene SCHEMBL27433216 0.76 CYP1A2 (0.44) KDM4ECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL8017494 0.75
Hydrochloric Acid SCHEMBL4489744 0.75
Water SCHEMBL7464138 0.75
SCHEMBL8014825 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103221396-B Biguanide derivative compound UNIV NIHON 2015-02-18 CN disclosed
CN-103221396-A Biguanide derivative compound UNIV SCHOOL NIHON JURIDIC PER 2013-07-24 CN disclosed
US-6872720-B2 Pyrazolo-triazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. 2005-03-29 US disclosed
US-20030060467-A1 Pyrazolo-triazine derivatives as ligands for gaba receptors MERCK SHARP & DOHME LTD. (GB) 2003-03-27 US disclosed
EP-1282623-A1 PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LTD. (GB) 2003-02-12 EP disclosed
WO-2001077111-A1 PYRAZOLO-TRIAZINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060467-A1 Pyrazolo-triazine derivatives as ligands for gaba receptors GABRA5, GABRA3, GABRA4 KDM4E 2798/4885CYP1A2 541/4885CYP3A4 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.